These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8508962)

  • 21. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
    Kanis JA
    Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
    [No Abstract]   [Full Text] [Related]  

  • 22. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
    Ohta H
    Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and treatment of osteoporosis in women.
    ; Al-Azzawi F; Barlow D; Hillard T; Studd J; Williamson J; Rees M
    Menopause Int; 2007 Dec; 13(4):178-81. PubMed ID: 18088530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance with drug therapies for the treatment and prevention of osteoporosis.
    McCombs JS; Thiebaud P; McLaughlin-Miley C; Shi J
    Maturitas; 2004 Jul; 48(3):271-87. PubMed ID: 15207894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
    Shintani M
    Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of osteoporosis and its economic aspects].
    Blachier C
    Cah Sociol Demogr Med; 1999; 39(2-3):271-82. PubMed ID: 10615567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoporosis in India--the nutritional hypothesis.
    Gupta A
    Natl Med J India; 1996; 9(6):268-74. PubMed ID: 9111786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic therapy for the treatment and prevention of osteoporosis.
    McClung B; McClung M
    Nurs Clin North Am; 2001 Sep; 36(3):433-40, viii. PubMed ID: 11532658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone densitometry as a screening tool for osteoporosis in postmenopausal women.
    Radiol Manage; 1998; 20(2):43-54. PubMed ID: 10179192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current considerations of the menopause.
    Wu CH
    Ann Clin Lab Sci; 1985; 15(3):219-28. PubMed ID: 3994291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
    Yates J; Barrett-Connor E; Barlas S; Chen YT; Miller PD; Siris ES
    Obstet Gynecol; 2004 Mar; 103(3):440-6. PubMed ID: 14990403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Osteoporosis].
    Netelenbos JC
    Ned Tijdschr Tandheelkd; 1998 Nov; 105(11):419-22. PubMed ID: 11928464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and management of osteoporosis.
    World Health Organ Tech Rep Ser; 2003; 921():1-164, back cover. PubMed ID: 15293701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.